CUV fundamentals
CLINUVEL PHARMACEUTICALS LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of CUV for the last semiannual is 55.92 M AUD, and it's 73.36% higher compared to the previous semiannual. The net income of H2 24 is 24.70 M AUD.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: AUD
TTM